PCLVX
Price
$23.90
Change
+$0.27 (+1.14%)
Updated
Dec 3 closing price
Net Assets
780.96M
VVIAX
Price
$74.33
Change
+$0.66 (+0.90%)
Updated
Dec 3 closing price
Net Assets
207.95B
Interact to see
Advertisement

PCLVX vs VVIAX

Header iconPCLVX vs VVIAX Comparison
Open Charts PCLVX vs VVIAXBanner chart's image
PACE Large Co Value Equity P
Price$23.90
Change+$0.27 (+1.14%)
VolumeN/A
Net Assets780.96M
Vanguard Value Index Adm
Price$74.33
Change+$0.66 (+0.90%)
VolumeN/A
Net Assets207.95B
PCLVX vs VVIAX Comparison Chart in %
View a ticker or compare two or three
VS
PCLVX vs. VVIAX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCLVX is a Buy and VVIAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 208B vs. PCLVX (781M). VVIAX pays higher dividends than PCLVX: VVIAX (2.04) vs PCLVX (1.50). PCLVX was incepted earlier than VVIAX: PCLVX (30 years) vs VVIAX (25 years). PCLVX (0.90) is less costly to investors than VVIAX (0.05). PCLVX is a more actively managed with annual turnover of: 43.00 vs. VVIAX (9.00). VVIAX has a lower initial minimum investment than PCLVX: VVIAX (3000) vs PCLVX (10000). VVIAX annual gain was more profitable for investors over the last year : 6.10 vs. PCLVX (4.50). VVIAX return over 5 years is better than : 60.40 vs. PCLVX (21.85).
PCLVXVVIAXPCLVX / VVIAX
Total Expense Ratio0.890.051,780%
Annual Report Gross Expense Ratio0.900.051,800%
Fund Existence30 years25 years-
Gain YTD18.55212.640147%
Front LoadN/AN/A-
Min. Initial Investment100003000333%
Min. Initial Investment IRAN/AN/A-
Net Assets781M208B0%
Annual Yield % from dividends1.502.0474%
Returns for 1 year4.506.1074%
Returns for 3 years15.4430.8250%
Returns for 5 years21.8560.4036%
Returns for 10 years20.70128.9016%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALLO1.520.18
+13.43%
Allogene Therapeutics
BCAB0.830.05
+6.00%
BioAtla
AGIO27.490.51
+1.89%
Agios Pharmaceuticals
WTGUU10.30N/A
N/A
Wintergreen Acquisition Corp.
UGI37.64-0.49
-1.29%
UGI Corp